MCL0129 T27986
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MCL0129, a selective and non-peptidergic melanocortin 4 (MC4) receptor antagonist, is a potential treatment for cachexia.
CAS nr:
768357-45-5
Purity:
98%
Molecular Weight:
546,78
SMILES:
CC(N1CCN([C@@H](C2=CC=C(F)C=C2)CN3CCN(CCCCC4=C5C=CC=CC5=CC=C4OC)CC3)CC1)C
Formula:
C34H47FN4O
Pathway:
Target:
